Soluble CD26 could interfere with this role of ADA in many pathological conditions, such as obesity and several viral infections, where its concentration is highly increased, but not in healthy physiological conditions, where its concentration (up to 4 nM) is much lower than its affinity for ADA (see Yu et al., 2011). Here, ADA is linked to viral infectious disease.